Life Sciences Tools and Services
Company Overview of KineMed, Inc.
KineMed, Inc. develops and commercializes proprietary biomarker platform technology. The company focuses on applying its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs with diagnostic biomarker tests. It plans to commercialize biomarkers in the areas of muscle biology, fibrotic diseases, neurodegenerative diseases, cardiometabolic diseases, skin care, and cancer. The company has an agreement with BioPharma Forest, Inc. to develop and commercialize synthetic Ghrelin. KineMed, Inc. was founded in 2001 and is based in Emeryville, California.
5980 Horton Street
Emeryville, CA 94608
Founded in 2001
Key Executives for KineMed, Inc.
KineMed, Inc. Key Developments
Similar Private Companies By Industry
|BioDot, Inc.||United States|
|Dormir Clinical Trials, Inc.||United States|
|ChemDiv, Inc.||United States|
|Global Pharma Analytics||United States|
|Huxley Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
June 11, 2015
To contact KineMed, Inc., please visit www.kinemed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.